evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract
3052,GENE_SUMMARY,,"PIK3R1, the regulatory subunit of PI3-kinase, is mutated in various cancers, most frequently in glioma, endometrial and colorectal cancers.",,2017-04-21,,5295,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,False,ENST00000274335,NM_181523.2,p85-ALPHA,GRB1,IMD36,p85,AGM7,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3053,GENE_BACKGROUND,,"PIK3R1 encodes p85α, the regulatory subunit of phosphatidylinositol-3-kinase (PI3K)(PMID: 12040186). In the absence of upstream receptor tyrosine kinase (RTK) activation, p85α both stabilizes and inhibits the activity of p110α, the catalytic subunit of PI3K. Upon RTK activation, p85α binds to phosphorylated tyrosine residues on the cytoplasmic tails of RTKs. Subsequently, this recruits the PI3K enzymatic complex to the cell membrane and allows the p110α catalytic subunit to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3) (PMID: 12040186, 1707345, 2833705). The production of PIP3 results in recruitment and activation of the serine/threonine kinase, AKT, which in turn activates numerous downstream targets (e.g. mTOR) involved in cell growth, proliferation and survival (PMID: 12094235). PIK3R1 mutations occur most frequently in its two SRC Homology 2 (SH2) domains, nSH2 and iSH2 (PMID: 21478295, 19962665). These mutations disrupt the ability of p85α to inhibit the PI3K catalytic subunit, thus resulting in aberrant activation of AKT-mTOR signaling (PMID: 9450999, 11606375, 15932879, 17626883, 18079394, 19962665,). Across all tumor types, PIK3R1 mutations tend to be mutually exclusive with alterations in TP53, PIK3CA, SETD2 and WT1 (PMID: 24132290). PIK3R1 mutations are prevalent in glioblastoma and to a lesser extent in endometrial, breast and colorectal cancers (PMID: 23636398, 24120142, 17932254, 22810696).",,2017-10-18,,5295,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,False,ENST00000274335,NM_181523.2,p85-ALPHA,GRB1,IMD36,p85,AGM7,True,24132290,Mutational landscape and significance across 12 major cancer types.,Nature,2018-10-17T20:13:00,502,7471,333-339,Kandoth C et al,doi: 10.1038/nature12634,,2018-10-17T03:39:00,,12040186,The phosphoinositide 3-kinase pathway.,"Science (New York, N.Y.)",2018-05-31T20:02:00,296,5573,1655-7,Cantley LC,,,0001-05-31,,15932879,Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit.,The Journal of biological chemistry,2018-07-29T20:05:00,280,30,27850-5,Shekar SC et al,,,0001-07-29,,1707345,"Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.",Cell,0001-04-05,65,True,91-104,Otsu M et al,,,2018-04-05T01:04:00,,9450999,Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase.,The EMBO journal,0001-02-02,17,3,743-53,Jimenez C et al,,,0001-02-02,,18079394,The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.,"Science (New York, N.Y.)",2017-12-14T20:07:00,318,5857,1744-8,Huang CH et al,,,0001-12-14,,22810696,Comprehensive molecular characterization of human colon and rectal cancer.,Nature,2018-07-18T20:12:00,487,7407,330-7,Cancer Genome Atlas Network.,doi: 10.1038/nature11252,,0001-07-18,,21478295,PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.,Cancer research,2018-06-15T20:11:00,71,12,4061-7,Urick ME et al,doi: 10.1158/0008-5472.CAN-11-0549,,0001-06-15,,11606375,The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.,Cancer research,2018-10-15T20:01:00,61,20,7426-9,Philp AJ et al,,,0001-10-15,,17626883,Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.,"Science (New York, N.Y.)",2018-07-13T20:07:00,317,5835,239-42,Miled N et al,,,0001-07-13,,24120142,The somatic genomic landscape of glioblastoma.,Cell,2018-10-10T20:13:00,155,2,462-77,Brennan CW et al,doi: 10.1016/j.cell.2013.09.034,,0001-10-10,,2833705,"Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.",Nature,0001-04-14,332,6165,644-6,Whitman M et al,,,0001-04-14,,23636398,Integrated genomic characterization of endometrial carcinoma.,Nature,2018-05-02T20:13:00,497,7447,67-73,Cancer Genome Atlas Research Network. et al,doi: 10.1038/nature12113,,0001-05-02,,12094235,The phosphatidylinositol 3-Kinase AKT pathway in human cancer.,Nature reviews. Cancer,2018-07-01T20:02:00,2,7,489-501,Vivanco I et al,,,2018-07-01T05:01:00,,19962665,Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.,Cancer cell,2017-12-08T20:09:00,16,6,463-74,Jaiswal BS et al,doi: 10.1016/j.ccr.2009.10.016,,0001-12-08,,17932254,The genomic landscapes of human breast and colorectal cancers.,"Science (New York, N.Y.)",2017-11-16T20:07:00,318,5853,1108-13,Wood LD et al,,,0001-11-16,
